C
ENZ

Covestor’s Enzo Biochem, Inc. ENZ Stock Holding History

Covestor’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,967
Closed -$4K – 2848
2024
Q3 		$4K Hold
3,967
– – ﹤0.01% 1755
2024
Q2 		$4K Hold
3,967
– – ﹤0.01% 1794
2024
Q1 		$5K Hold
3,967
– – ﹤0.01% 1789
2023
Q4 		$6K Hold
3,967
– – ﹤0.01% 1758
2023
Q3 		$6K Buy
+3,967
New +$5.98K ﹤0.01% 1705

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Covestor's ENZ Position: Q4 2024 in Review

Covestor sold out of Enzo Biochem, Inc. (ENZ) in Q4 2024, closing a stake of 3,967 shares — an estimated $4K sold.

Covestor first reported a position in ENZ in Q3 2023 and held it in 5 quarters. The position peaked at $6K in Q4 2023. 45 funds tracked by Wall St. Rank hold ENZ as of Q4 2024.

  • Covestor reported no remaining Enzo Biochem, Inc. position as of Q4 2024 after selling out during the quarter.
  • Covestor sold 3,967 Enzo Biochem, Inc. shares in Q4 2024, an estimated $4K.
  • Covestor first reported a position in Enzo Biochem, Inc. in Q3 2023 and held it in 5 quarters.
  • Covestor's Enzo Biochem, Inc. position peaked at $6K in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2024.

Based on Covestor's 13F filing for Q4 2024, filed 13 Feb 2025.